Literature DB >> 23907077

Exercise interventions for upper limb dysfunction due to breast cancer treatment.

Mary Lou Galantino1, Nicole L Stout.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23907077     DOI： 10.2522/ptj.20120049

Source DB:  PubMed          Journal:  Phys Ther        ISSN： 0031-9023


× No keyword cloud information.
  6 in total

1.  A Systematic Review of Electronic Health (eHealth) interventions to improve physical activity in patients with breast cancer.

Authors:  Sara Dorri; Farkhondeh Asadi; Asiie Olfatbakhsh; Alireza Kazemi
Journal:  Breast Cancer       Date:  2019-06-12       Impact factor: 4.239

Review 2.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

3.  Effect of physical activity levels on oncological breast surgery recovery: a prospective cohort study.

Authors:  Ifat Klein; Leonid Kalichman; Noy Chen; Sergio Susmallian
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

4.  Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.

Authors:  Mariana Maia Freire de Oliveira; Maria Salete Costa Gurgel; Bárbara Juarez Amorim; Celso Dario Ramos; Sophie Derchain; Natachie Furlan-Santos; César Cabello Dos Santos; Luís Otávio Sarian
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 5.  The potential role of angiogenesis in the development of shoulder pain, shoulder dysfunction, and lymphedema after breast cancer treatment.

Authors:  Trevor S Mafu; Alison V September; Delva Shamley
Journal:  Cancer Manag Res       Date:  2018-01-15       Impact factor: 3.989

6.  Effect of different rehabilitation training timelines to prevent shoulder dysfunction among postoperative breast cancer patients: study protocol for a randomized controlled trial.

Authors:  Yu-Wei Shao; Qing Shu; Dan Xu; Hui Teng; Gao-Song Wu; Jin-Xuan Hou; Jun Tian
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.